Using PK/PD M&S for Pediatric Drug Development: Regulatory Insights into Practical Issues

This webinar addressed some of the challenges associated with pediatric drug development and the advantages (and limitations) that pediatric population PK modeling can provide.



Powered by Translations.com GlobalLink OneLink Software